The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes, Roche said on Monday. Sign up here.

Life of Joy - Gallop- Churchill Downs - 04-08-2026 Coady Media/Renee Torbit Life of Joy - Morning - Churchill Downs - 040726 Coady Media Life of Joy - Morning - Churchill Downs - 040726 Coady Media ...

Oral bacteria colonizing the gut — quantified using a new “mouth-to-feces” (MF) transmission index — were significantly more abundant in patients with gastric and colorectal cancer, enabling ...

Roche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic. The Elecsys pTau217, developed by Roche in conjunction with Lilly, is a blood test designed to detect ...

People who participated in colorectal cancer screening had a 43% lower risk of dying from the disease, according to long-term data from more than 376,000 people in Sweden. The findings suggest that ...

GLO volunteers and contractors gather and test water samples for enterococcus bacteria, a potentially harmful bacterium that can indicate the level of fecal matter in the water. GLO officials call ...

People who take part in screening for colorectal cancer may have as much as 43 per cent lower risk of dying from the disease, according to new estimates published in JAMA Network Open by researchers ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Ovarian cancer remains one of the most lethal gynecologic malignancies worldwide, with a high risk of recurrence even after successful initial treatment. Over the past decade, poly(ADP-ribose) ...

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more. How ...

Millions of Americans skip cancer screening because it feels invasive, awkward or easy to postpone. Only about 65 percent of eligible adults are currently up to date on colorectal cancer checks. Stool ...